The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Get to know the new WCMM co-director!

Kristian Pietras porträtt
Photo: Melker Dahlstrand

On January 1, 2024, Wallenberg Centre Lund got a new preclinical co-director. Professor Kristian Pietras will replace Jonas Larsson, who recently started his new position as Deputy Dean. Welcome to the team!

| How does it feel becoming the next preclinical co-director of WCMM Lund?
"I am honored to take on this position and really look forward to working with everyone within the centre to create the best possible conditions for cutting-edge science."

| What are your expectations for this role?
"I am excited to take part in this active community and in particular learn how clinical and pre-clinical investigators interact in practice. Looking ahead, the upcoming recruitment of new fellows for WCMM, and the integration with the DDLS program will be a great opportunity to develop the centre further, and I am eager to understand how this can be done in the best way."

| How do you think your expertise can contribute to the centre?
"I would like to contribute my experience in building research communities, both at the local level where I have led the establishment of Lund University Cancer Centre, and at the national level where I have served as the chairman of the Young Academy of Sweden."

| What do you want to achieve?
"In five years’ time, I envision that WCMM will have developed an even closer integration between disciplines locally, and that the extended national WCMM/DDLS network will serve as a powerful platform for scientific collaborations and leadership development."

| Briefly, what is your research about?
"At the very basic level, we study tumour architecture in order to identify the organizing principles of the tumour ecosystem. With this knowledge, we aim to identify cellular niches and paracrine signalling hubs that may serve as points of intervention. Finally, we translate this basic knowledge into studies of patient cohorts and clinical trials with the aim of providing patient benefit through the use of rational drug combinations."

Kristian Pietras

Kristian Pietras

Professor, Dept. of Laboratory Medicine
Research group manager for Experimental Oncology
Academic Staff Representative in the current Faculty Board

Contact:kristian [dot] pietras [at] med [dot] lu [dot] se (kristian[dot]pietras[at]med[dot]lu[dot]se)

Profile in Lund University Research Portal